---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-204956"
form_type: "8-K"
ticker: "MNOV"
cik: "0001226616"
company_name: "MEDICINOVA INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:47:59.713296+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# MediciNova appoints Nicole Lemerond to Board, filling vacancy

## Summary
- Lemerond appointed as Class I director, term expiring at 2026 Annual Meeting.
- She joins Audit, Compensation, and Nominating Committees immediately.
- Granted option to purchase 18,333 shares vesting quarterly through June 30, 2024.
- Lemerond is former Managing Partner of NV Capital (2010-2022) with 25+ years in healthcare finance.
- No family relationships or material transactions with existing directors or officers.

## SEC filing metadata
- accession: 0001193125-23-204956
- form_type: 8-K
- ticker: MNOV
- cik: 0001226616
- company_name: MEDICINOVA INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1226616/000119312523204956/0001193125-23-204956-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1226616/000119312523204956/d533741d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-204956
- JSON: https://secwatch.observer/filing/0001193125-23-204956.json
- Plain text: https://secwatch.observer/filing/0001193125-23-204956.txt

## Key facts
- Executive change
  Nicole Lemerond was appointed as Member of the Board at MEDICINOVA INC.
  - Action: appointed
  - Role: Member of the Board
  source text: On August 4, 2023, the Board of Directors (the “Board”) of MediciNova, Inc. (the “Company”) appointed Nicole Lemerond as a member of the Board, effective immediately, filling an existing vacancy on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1226616/000119312523204956/0001193125-23-204956-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.